Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes

Azim, Tasnim; Bogaerts, J; Yirrell, David; Banerjea, Akhil C.; Sarker, Supta; Ahmed, Gehan M.; Amin, Mian M. M.; Rahman, Anisur; Hussain, A

doi:10.1097/00002030-200201040-00015

Cited by 31 publications

(21 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The sero-prevalence of syphilis (according to TPHA) of 3.3% in our study is comparable to the findings of studies carried out in the USA among drug abusers in treatment facilities [7,15,16], but it is much lower than 23% among injecting drug users in Bangladesh [17]. However, only 1 in 5 of the TPHA positive patients in our study (0.6% of all screened patients) was in need of treatment, all other patients were already treated or recovered from the disease; these proportions were not reported for the other countries and may significantly differ.…”

Section: Discussionsupporting

confidence: 86%

Prevalence and risk factors of syphilis infection among drug addicts

Scherbaum

Baune²,

Mikolajczyk

et al. 2005

BMC Infect Dis

View full text Add to dashboard Cite

Background: Recent epidemiological data show an increased trend of official estimates for syphilis infection in the general population. Many of the infected cases remain undetected leaving an underestimation of the true prevalence of syphilis in the general population, but also among subpopulations such as illicit drug users. There is limited epidemiological data published on the proportion and risk factors of syphilis infections associated with illicit drug abuse.

show abstract

Section: Discussionsupporting

confidence: 86%

Prevalence and risk factors of syphilis infection among drug addicts

Scherbaum

Baune²,

Mikolajczyk

et al. 2005

BMC Infect Dis

View full text Add to dashboard Cite

show abstract

“…Previous work in Bangladesh has identified HIV as a concern among IDUs in Bangladesh [5-7,9] and among MSM in India and Pakistan [24,25]. There has not been a clear link between the high risk groups of MSM and IDUs in Bangladesh, and this is the relationship we explore in this paper.…”

Section: Introductionmentioning

confidence: 93%

“…National surveillance data for HIV from the Ministry of Health and Government of Bangladesh have reported data from a variety of groups showing the highest levels of HIV infection were identified among IDUs [5-8]. During the first four rounds of surveillance, from 1998 to 2002, the HIV prevalence increased from nearly zero to 4%.…”

Section: Introductionmentioning

confidence: 99%

Risk factors for HIV infection in Males who have Sex with Males (MSM) in Bangladesh

Chan

Khan

2007

BMC Public Health

View full text Add to dashboard Cite

show abstract

“…HIV prevalence is generally low in the neighboring country of Bangladesh but is more than 5% in PWID in Dhaka, the capital of Bangladesh (Bontell et al, 2013). The epidemic in general and among PWID is subtype C-driven, and strains cluster with viruses from India and Myanmar (Azim et al, 2002; Bontell et al, 2013; Sarker et al, 2008). …”

Section: Molecular Epidemiology Of Hiv Among Pwid In Asiamentioning

confidence: 99%

Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia

Nikolopoulos

Kostaki

Paraskevis

2016

Infection, Genetics and Evolution

View full text Add to dashboard Cite

HIV strains continuously evolve, tend to recombine and new circulating variants are being discovered. Novel strains complicate efforts to develop a vaccine against HIV and may exhibit higher transmission efficiency and virulence, and elevated resistance to antiretroviral agents. The United Nations Joint Programme on HIV/AIDS (UNAIDS) set an ambitious goal to end HIV as a public health threat by 2030 through comprehensive strategies that include epidemiological input as the first step of the process. In this context, molecular epidemiology becomes invaluable as it captures trends in HIV evolution rates that shape epidemiological pictures across several geographical areas. This review briefly summarizes the molecular epidemiology of HIV among people who inject drugs (PWID) in Europe and Asia. Following high transmission rates of subtype G and CRF14_BG among PWID in Portugal and Spain, two European countries, Greece and Romania, experienced recent HIV outbreaks in PWID that consisted of multiple transmission clusters including subtypes B, A, F1 and recombinants CRF14_BG and CRF35_AD. The latter was first identified in Afghanistan. Russia, Ukraine and other Former Soviet Union (FSU) states are still facing the devastating effects of epidemics in PWID produced by AFSU (also known as IDU-A), BFSU (known as IDU-B), and CRF03_AB. In Asia, CRF01_AE and subtype B (Western B and Thai B) travelled from PWID in Thailand to neighboring countries. Recombination hotspots in South China, Northern Myanmar, and Malaysia have been generating several intersubtype and inter-CRF recombinants (e.g. CRF07_BC, CRF08_BC, CRF33_01B etc.) increasing the complexity of HIV molecular patterns.

show abstract

Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes

Cited by 31 publications

References 6 publications

Prevalence and risk factors of syphilis infection among drug addicts

Prevalence and risk factors of syphilis infection among drug addicts

Risk factors for HIV infection in Males who have Sex with Males (MSM) in Bangladesh

Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia

Contact Info

Product

Resources

About